Knowledge Hub
Expert Resources
Access comprehensive information about radiopharmaceutical theranostics, our preclinical services, and how to accelerate your development program.
FAQ
Frequently Asked Questions
Find answers to common questions about radiopharmaceutical theranostics and our preclinical services.
Radiopharmaceutical theranostics combines diagnostic imaging and targeted therapy using radioactive compounds. The same or similar molecular targeting agent is labeled with different radioisotopes—one for imaging to identify and locate tumors, and another for delivering therapeutic radiation directly to cancer cells. This approach enables personalized treatment by confirming target expression before therapy.